United States · FDA National Drug Code directory
YESAFILI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83257-035_783e32b7-6349-2a90-55c2-9e040cfe854e
- Product NDC
- 83257-035
- Form
- INJECTION, SOLUTION
- Composition / generic term
- aflibercept-jbvf
- Labeler
- Biocon Biologics Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260803
- Source listing expiry
- 20271231
Source-listed ingredients
- AFLIBERCEPT — 2 mg/.05mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (83257-035-41) / .05 mL in 1 SYRINGE, GLASS · 83257-035-41
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →